“The hardships of being a CEO in the OTC has taken its
“The hardships of being a CEO in the OTC has taken its toll.”
You’re being facetious, right?
Steve has brought the problems upon himself with essentially what would be considered an incorrect account of the truth. If you’d like me to post a prime example of why the doubt and share price decline exists, let me know. He’s back peddling in my opinion. I wish us well, but I will not justify Steve’s actions so easily.
3
On4 Communications (ONCI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Black & Veatch Tackles Energy Transition Challenges in Asia As Southeast Asia faces the increasing complexities of energy transitions, the region is striving to balance energy security with the urgent need to reduce carbon emissions. Black & Veatch stands at the forefront of this effort, offering critical solutions needed to navigate these changes effectively. Insights...
Continue Reading
Public Disclosure Overview for Primary Health Properties Plc When it comes to investing in publicly listed companies, transparency is vital for maintaining credibility and building trust among shareholders. This is particularly true for companies like Primary Health Properties Plc. Legislative frameworks, such as Rule 8.3 of the Takeover Code, dictate how and when...
Continue Reading
Intuit's Innovative AI-Powered Tax Solutions Intuit Inc. (Nasdaq: INTU), a leading financial technology platform, is redefining the way individuals manage their tax filings with its advanced AI-driven expert platform. By integrating innovative technology, Intuit offers a personalized and efficient "done-for-you" tax filing experience, enabling customers to secure maximum...
Continue Reading
Nu Skin's Strategic Sale of Mavely Platform Nu Skin Enterprises Inc. (NYSE: NUS) has taken a notable step in strengthening its market position with the sale of its Mavely affiliate marketing platform to Later, a reputable company backed by Summit Partners. This strategic transaction is valued at approximately $250 million, combining cash with a minority equity stake in...
Continue Reading
Debbie's Dream Foundation Celebrates Advocacy for Stomach Cancer Research In a remarkable gathering advocating for stomach cancer research, nearly 200 advocates united to voice their concerns on Capitol Hill. This historic event was organized by Debbie's Dream Foundation: Curing Stomach Cancer (DDF), emphasizing the need for increased federal funding due to potential...
Continue Reading
